Flunarizine prevents demyelination and neurological deficits in a cuprizone-induced mouse model of multiple sclerosis
Gopika Venu, S. S. Binil Raj · 2026
Read Flunarizine prevents demyelination and neurological deficits in a cuprizone-induced mouse model of multiple sclerosis by Gopika Venu, S. S. Binil Raj (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610805.txt.
Description
Gopika Venu and S Binil Raj test a migraine drug as a shield for myelin in a 2026 mouse study. Multiple sclerosis strips the insulation from brain wiring, and current drugs mostly calm the immune system rather than save the insulation itself. Protecting myelin directly is the field's biggest unmet need.
Mice ate a toxin-laced diet for six weeks to dissolve myelin, while some also received flunarizine by mouth at one of two doses. Treated mice kept better balance, movement, and memory, and showed less anxiety on standard mazes and wheels. Brain chemistry shifted toward protection, with serotonin up and stress markers down. Stains showed healthier tissue and more myelin preserved. The authors read flunarizine, long used for migraine and vertigo, as a credible repurposing candidate worth deeper study.
Catalog record
| CREATOR | Gopika Venu, S. S. Binil Raj |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |